Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|16|3|179-185

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.16, Iss.3, 2016-02, pp. : 179-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Studying the Human Gut Microbiota in the Trans-Omics Era - Focus on Metagenomics and Metabonomics

By  

Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. : 1415-1427

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Modulation of Gut Microbiota: Current Clinical Applications and Future Perspectives

By  

Current Drug Targets, Vol. 15, Iss. 8, 2014-07 ,pp. : 762-770

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of the Maturing Gut Barrier and Microbiota: A Novel Target in Allergic Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 14, 2008-01 ,pp. : 1368-1375

Bentham Science Publishers

Access to resources Recommend Favorite

Understanding the Molecular Mechanisms of Rifaximin in the Treatment of Gastrointestinal Disorders – A Focus on the Modulation of Host Tissue Function

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 3, 2016-02 ,pp. : 206-217

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Digestible Food Ingredients, Colonic Microbiota and the Impact on Gut Health and Immunity: A Role for Metabolomics

By  

Current Drug Metabolism, Vol. 10, Iss. 1, 2009-01 ,pp. : 41-54

Bentham Science Publishers

Access to resources Recommend Favorite